Retatrutide is a new medication in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, Retatrutide https://susanhxxt999438.activablog.com/35411202/retatrutide-a-promising-new-treatment-for-obesity